Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation

Cancer Research

Volumn 58, Issue 5, 1998, Pages 1057-1062

  Mason, David Y ^a   Pulford, Karen A F ^a   Bischof, Daniela ^b   Kuefer, Martin U ^b   Butler, Lisa H ^a   Lamant, Laurence ^c   Delsol, Georges ^c   Morris, Stephan W ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b Children's Research Hospital   (United States)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOPLASMIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 4; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; LYMPHOMA; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NUCLEAR PROTEINS; PROTEIN-TYROSINE KINASES; RATS; RECOMBINANT FUSION PROTEINS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032031083     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mason, D. Y., Bastard, C., Rimokh, R., Dastugue, N., Huret, J-L., Kristoffersson, U., Magaud, J-P., Nezelof, C., Tilly, H., Vannier, J-P., Hemet, J., and Warnke, R. CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br. J. Haematol., 74: 161-168, 1990.
2. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., and Look, A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science (Washington DC), 263: 1281-1284, 1994.
3. Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., and Yamamoto, T. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. USA, 93: 4181-4186, 1996.
4. Bischof, D., Pulford, K., Mason, D. Y., and Morris, S. W. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol. Cell. Biol., 17: 2312-2325, 1997.
5. Kuefer, M. U., Look, A. T., Pulford, K., Behm, F. G., Pattengale, P. K., Mason, D. Y., and Morris, S. W. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood, 90: 2901-2910, 1997.
6. Lamant, L., Meggetto, F., Al Saati, T., Brugières, L., de Paillerets, B. B., Dastugue, N., Bernheim, A., Rubie, H., Terrier-Lacombe, M. J., Robert, A., Brousset, P., Rigal, F., Schlaifer, D., Shiota, M., Mori, S., and Delsol, G. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood, 87: 284-291, 1996.
7. Delsol, G., Chittal, S., Brousset, P., Caverivière, P., Roda, D., Mazerolles, C., Barillet-Alard, C., Al Saati, T., Gorguet, B., and Voigt, J-J. Immunohistochemical demonstration of leucocyte differentiation antigens on paraffin sections using a modified AMeX (ModAMex.) method. Histopathology, 15: 461-471, 1989.
8. Seed, B., and Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA, 84: 3365-3369, 1987.
9. Pulford, K., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., and Mason, D. Y. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood, 89: 1394-1404, 1997.
10. Morris, S. W., Naeve, C., Mathew, P., James, P. L., Kirstein, M. N., Cui, X., and Witte, D. P. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14: 2175-2188, 1997.
11. Rodrigues, G. A., and Park, M. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol. Cell. Biol., 13: 6711-6722, 1993.
12. Shiota, M., Nakamura, S., Ichinohasama, R., Abe, M., Akagi, T., Takeshita, M., Mori, N., Fujimoto, J., Miyauchi, J., Mikata, A., Nanba, K., Takami, T., Yamabe, H., Takano, Y., Izumo, T., Nagatani, T., Mohri, N., Nasu, K., Satoh, H., Katano, H., Fujimoto, J., Yamamoto, T., and Mori, S. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood, 86: 1954-1960, 1995.
13. Shiota, M., Fujimoto, J., Takenaga, M., Satoh, H., Ichinohasama, R., Abe, M., Nakano, M., Yamamoto, T., and Mori, S. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood, 84: 3648-3652, 1994.
14. NPM/ALK. Leuk Lymphoma, 23: 25-32, 1996.
15. Yee, H. T., Ponzoni, M., Merson, A., Goldstein, M., Scarpa, A., Chilosi, M., Menestrina, F., Pittaluga, S., de Wolf Peeters, C., Shiota, M., Mori, S., Frizzera, G., and Inghirami, G. Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood, 87: 1081-1088, 1996.
16. Chan, P. K., and Chan, F. Y. Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells. Biochim. Biophys. Acta, 1262: 37-42, 1995.
17. Greco, A., Pierotti, M. A., Bongarzone, I., Pagliardini, S., Lanzi, C., and Della Porta, G. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene, 7: 237-242, 1992.
18. King, H. W., Tempest, P. R., Merrifield, K. R., and Rance, A. J. tpr homologues activate met and raf. Oncogene, 2: 617-619, 1988.
19. Van Etten, R. A., Jackson, P., and Baltimore, D. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell, 58: 669-678, 1989.
20. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., and Dejean, A. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell, 76: 345-356, 1994.
21. Dyck, J. A., Maul, G. G., Miller, W. H., Jr., Chen, J. D., Kakizuka, A., and Evans, R. M. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell, 76: 333-343, 1994.
22. Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., and Yamamoto, T. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene, 14: 439-449, 1997.
23. Yoneda-Kato, N., Look, A. T., Kirstein, M. N., Valentine, M. B., Raimondi, S. C., Cohen, K. J., Carroll, A. J., and Morris, S. W. The t(3;5)(q25.1;q34) of myelodys-plastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene, 12: 265-275, 1996.
24. Redner, R. L., Rush, E. A., Faas, S., Rudert, W. A., and Corey, S. J. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood, 87: 882-886, 1996.